Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
1602009905-118312012de6afc5
Name
Kush M Parmar, M.D., Ph.D.
Title
Managing Partner, 5AM Venutres
Bio
Dr. Parmar serves as a Director on the Boards of Akouos (NASDAQ: AKUS), Entrada, Homology (NASDAQ: FIXX), Rallybio and Vor Biopharma. He previously served as Board Member or Observer for Achaogen (NASDAQ: AKAO), Arvinas (NASDAQ: ARVN), Audentes (NASDAQ: BOLD), Envoy (acquired by Takeda) and scPharmaceuticals (NASDAQ: SCPH) and as Acting VP of Strategy and Corporate Development at Novira (acquired by J&J). Dr. Parmar serves on the Advisory Boards of Harvard Medical School, Penn Medicine, Princeton University’s Department of Molecular Biology, and the Grace Science Foundation. He is a Fellow of the Society of Kauffman Fellows. Prior to 5AM, Dr. Parmar was at Harvard Medical School, where he was an NIH-sponsored M.D./Ph.D. Physician Scientist Fellow in the Harvard-MIT Health Sciences and Technology Program. He holds an A.B. in Molecular Biology and Medieval Studies from Princeton University, a Ph.D. in Experimental Pathology from Harvard University and an M.D. from Harvard Medical School